ABSTRACT Reduced weight gains and feed conversions are major sources of economic losses from avian coccidiosis. Experiments were conducted to determine possible involvement of up-regulation of cyclooxygenase (COX) activity during coccidia infections that might contribute to reduced weight gain. In a series of trials, young (3 to 5 wk of age) cockerels infected with Eimeria acervulina, a duodenal parasite, received oral treatments with indomethacin (IM), an inhibitor of both COX-1 and COX-2, or nimesulide (NIM), a specific inhibitor of COX-2. Infection doses varied with experiment (from 10 5 to 10 6 oocysts per chick). Effects of infection on weight gain, duodenal lesions, plasma carotenoids, and levels of NO 2 -+ NO 3 -were determined at 6 d postinoculation. Total oocysts were enumerated in feces collected from 5 through 8 d postinoculation from separate replicate groups. In no trials did treatment with IM reverse effects of infection on weight gain or significantly reduce lesion
INTRODUCTION
Poor weight gain and feed conversion are characteristic of coccidiosis infections in naive chickens infected with Eimeria acervulina, particularly through the 4-to 7-d period after infection, when the parasite is rapidly reproducing in the duodenum and upper jejunum. Anorexia, changes in metabolism, and composition of tissues remote from infection (Ruff et al., 1981; Ruff and Allen, 1982; Allen and McMurtry, 1984; Allen, 1987) suggest that systemic effects may accompany local coccidia infections. This explanation is discussed by Ryley (1975) in an early review on the pathogenesis of coccidia infections. Recently, it has become apparent that macrophages of the avian immune system, through their capacity to secrete an extensive variety of bioregulatory molecules (Klasing, 1998) , may be important players in the pathology of coc-1 To whom correspondence should be addressed: pallen@lpsi. barc.usda.gov.
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scores. However, in all trials, IM treatment reduced oocyst output per chick (Trial 1, 15%; Trial 2, 19%; Trial 3, 53%; Trial 4, 29%; Trial 5, 28.5%). Supplementation of feed with 400 and 100 ppm NIM significantly reduced weight gain of, and increased oocyst output from, infected chicks, whereas supplementation with 50 ppm NIM had no beneficial effects on weight gain or lesion scores, but reduced oocyst shedding. The inability of the IM and NIM treatments to reverse infection-associated weight gain suppression suggests that this pathological effect is not linked to increased prostanoid synthesis as a result of COX-2 up-regulation during infection. The inhibitory effects of IM treatment on oocyst shedding suggest that COX-2 products may have immunosuppressive effects in coccidia infection at local sites of infection. The stimulating effects of high-dose NIM treatments on oocyst shedding suggest that this compound may inhibit synthesis of other prostanoids as well.
cidiosis. For example, chicken macrophages can be stimulated by Eimeria tenella antigens (Zhang et al., 1995) to produce tumor necrosis factor alpha (TNF-α), and macrophages from coccidia-infected chickens secrete significantly greater amounts of the proinflammatory cytokines interleukin-1 (IL-1) and tumor necrosis factor alpha, than macrophages from uninfected controls (Byrnes et al., 1993) . Treatment of chickens with cytokines released from cultured macrophages can stunt growth (Klasing, 1987; Klasing and Johnstone, 1991) . Sickness behavior observed in coccidia-infected chickens such as anorexia, lethargy, and fever (Allen, 1993) can be duplicated by treating chickens with interleukin-1 . Activated avian macrophages can also elaborate NO as a result of up-regulation of induced nitric oxide synthase (iNOS) (Sung et al., 1991) and PGE 2 (Korver and Klasing, 1995) . These bioregulators not only can affect the physiology of the infected host, but may impact the development of invading pathogens as well.
As part of a study on possible adverse impacts of inflammatory reactions on production parameters during coccidia infection, chickens were treated with cyclooxygenase (COX) inhibitors to determine whether increases in prostanoids, such as PGE 2 and thromboxane (TX), might be associated with reduced weight gain in chickens infected with E. acervulina. Indomethacin (IM), a nonspecific inhibitor that should affect both constitutive (COX-1) and induced (COX-2) enzymes, and nimesulide (NIM), a COX-2 specific inhibitor (Cullen et al., 1998) , were administered either in discrete oral doses or in the diet. Their effects on weight gain, lesion scores, and oocyst shedding were observed. Plasma levels of carotenoids and NO 2 -+ NO 3 -were monitored to provide indicators of infection severity and activation of inflammation, respectively (Miller and Sandoval, 1999) .
MATERIALS AND METHODS

Chickens and Housing
All chickens were SexSal cockerels 2 (White Rock × Rhode Island Red), obtained at 1 d of age. They were raised in brooders 3 for 2 wk, then housed in suspended wire cages with five to six birds per cage. The birds had access ad libitum to water and a broiler starter ration. 4 Housing temperature of caged birds ranged from 25 to 28 C. Lighting was continuous.
General Experimental Design
In all trials, chicks were sorted into four, equivalent mean weight-treatment groups (Gardiner and Wehr, 1950) of approximately 10 chicks each (two cages per group): nontreated, uninfected (NU); treated, uninfected (TU); nontreated, infected (NI); and treated, infected (TI). Infections were initiated when chicks were 2-or 3-wkold. Weight gains and lesion scores were determined, and blood samples were taken at 6 d postinfection. In order to avoid accidental contamination of control groups, infected chicks were housed in separate but comparable conditions from uninfected chicks. The Beltsville Area Animal Care and Use Committee approved all experimental procedures (AUP 97-022).
Parasites
Eimeria acervulina #12 is a laboratory strain purified by single oocyst isolation from an Alabama field strain and propagated at the Parasite Biology and Epidemiology Laboratory by periodic passage through chickens. This species parasitizes primarily the duodenal mucosal epithelium of the chicken. Oocysts, isolated from feces and cleaned, were stored in 2.5% K 2 Cr 2 O 7 at 4 C. For use, the K 2 Cr 2 O 7 was washed out with water by repeated centrifugation, and suspensions were diluted to concentrations that delivered the desired number of oocysts in 1 mL of water.
Cyclooxygenase Inhibitors
Indomethacin.
5 For oral dosing, IM was dissolved in minimum volumes of ethanol and then diluted with 0.5% NaHCO 3 in 0.9% NaCl to provide the desired dose per kilogram body weight in volumes up to 1 mL per chick. Single daily doses were given by gavage at 0800, beginning 1 d prior to infection. Dual daily doses were administered at 0800 and 1630. When provided in the diet, IM was mixed at 50 mg/kg with broiler starter feed that had been ground to a mash, and the feeding of this ration commenced the day prior to infection.
Nimesulide. 6 Because this compound was not conveniently soluble in aqueous media, it was mixed with broiler starter ration at levels of 400, 100, and 50 ppm. Feeding of these rations commenced the day prior to infection.
Oocyst Shedding
In each experiment, three replicate cages of infected chicks (three to four chicks per cage), treated identically to others in the NI and TI groups, were set aside to determine oocyst shedding. Feces were collected from 5 through 8 d postinfection and homogenized in water. Duplicate counts of duplicate aliquots were made using McMasters type chambers (Conway and McKenzie, 1991) , and the oocysts shed per chick was calculated.
Lesion Scores
Gross mucosal lesions in the chick duodenum caused by E. acervulina were scored according to Johnson and Reid (1970) .
Analyses
Plasma carotenoids were analyzed spectrophotometrically (Allen et al., 1996) . Levels of NO 2 -+ NO 3 -were analyzed (Allen, 1997) (Verdon et al., 1995) .
Statistics
Data on weight gains, oocyst shedding, plasma carotenoids, and NO 2 -to NO 3 -were analyzed using the general linear models procedure of SAS (SAS Institute Inc., 1990) to determine main effects. Differences among group means were determined using Duncan's multiple range test. Lesion score data were analyzed nonparametrically using the NPAR1WAY procedure of SAS. The experimental unit was considered to be an individual chicken.
Trials with Indomethacin
Trial 1. Two-week-old chicks in the TU and TI groups were given oral doses of 5 mg/kg IM once daily from 1 d before time of inoculation with 1 × 10 6 sporulated oocysts of E. acervulina through 8 d postinoculation (PI).
Trial 2. Three-week-old chickens in the TU and TI groups were given oral doses of 3 mg/kg IM twice daily from 1 d before time of inoculation with 5 × 10 5 sporulated oocysts of E. acervulina through 8 d PI. It was discovered that this oocyst preparation was contaminated with low levels of Eimeria maxima and E. tenella. Therefore, the intestinal tract was scored for lesions in all areas where these parasites infect.
Trial 3. Three-week-old chickens in the TU and TI groups were treated orally with 6 mg/kg IM twice daily from 1 d before inoculation with 1 × 10 5 sporulated oocysts of E. acervulina through 8 d PI. This and subsequent preparations contained no other coccidia species.
Trial 4. Five-week-old chickens in the TU and TI groups were treated orally with 6 mg/kg IM twice daily from 1 d before time of inoculation with 5 × 10 5 sporulated oocysts of E. acervulina through 8 d PI.
Trial 5. Three-week-old chicks in the TU and TI groups were provided starter feed containing 50 mg/kg IM from 1 d before inoculation with 5 × 10 5 sporulated oocysts of E. acervulina through 8 d PI.
Trials with Nimesulide
Trial 1. Three-week-old chicks in the TU and TI groups were provided starter feed containing 400 mg/kg NIM, beginning 1 d before inoculation with 1 × 10 5 sporulated oocysts of E. acervulina.
Trial 2. Three-week-old chicks in the TU and TI groups were provided feed containing 100 mg/kg NIM, beginning 1 d before inoculation with 1 × 10 5 sporulated oocysts of E. acervulina.
Trial 3. Three-week-old chicks in the TU and TI groups were provided starter feed containing 50 mg/kg NIM, beginning 1 d before inoculation with 5 × 10 5 sporulated oocysts of E. acervulina.
RESULTS
Effects of Indomethacin
In Trials 2, 3, and 5, treatment with IM did not significantly affect weight gain of TU chickens compared with NU chicks (Table 1) . Plasma carotenoids from the TU group were significantly higher than those from the NU group in Trial 2, but were significantly lower in Trials 4 and 5 (Table 2) . Additionally, plasma NO 2 -+ NO 3 -was not significantly increased by IM treatment in TU chicks (Table 2) . In all trials, treatment with IM did not reverse effects of infection on weight gain, and did not lower gross lesion scores (Table 1) . However, in Trials 1, 2, 3, and 5, IM treatment significantly reduced oocyst shedding (Table 1) . In Trial 4, oocyst shedding was also reduced, but because of the large variation in counts, the reduction was not significant. In Trials 1 through 4, infection with E. acervulina reduced plasma carotenoids by about 74% (Table 2) , and there was no interaction of IM treatment with carotenoid levels. In Trials 1, 2, and 4, infection also caused at least a doubling of plasma NO 2 -+ NO 3 - (Table 2 ). This effect was not observed in Trial 3. In Trial 5, infection reduced plasma carotenoids by about 76%, but there was an interaction with the IM treatment in that it significantly reduced carotenoids in the TU group compared with the NU group. Additionally, IM significantly increased plasma NO 2 -+ NO 3 -in TI birds, which is demonstrated by the significantly higher levels in the TI group than in the NI group (Table 2) .
Effects of Nimesulide
In all trials, treatment with NIM had no significant impact on weight gain or plasma NO 2 -+ NO 3 -of TU chickens (Tables 3 and 4) . However, compared with the NU group, plasma carotenoids were significantly reduced in the TU group fed 100 mg/kg NIM. The effects of NIM on weight gain and oocyst shedding in infected chickens varied with the NIM level in the feed (Table 3) . Chicks from the TI group that consumed 400 mg/kg gained significantly less, but also shed significantly higher numbers of oocysts than NI chicks. On the other hand, no significant differences in weight gain were observed between chicks from NI and TI groups that consumed the 100 and 50 mg/kg NIM feed. However, the TI group that consumed 100 mg/kg NIM shed significantly more oocysts than the NI group, whereas the TI group that consumed 50 mg/kg NIM shed fewer oocysts than the NI group (Table 3) . No level of NIM treatment significantly lowered lesion scores. Infection significantly reduced plasma carotenoids, with no interaction with NIM level (Table 4) . At all three levels of NIM, infection significantly increased plasma NO 2 -+ NO 3 -. Chicks in the TI groups that consumed 400 or 50 mg/kg had significantly higher NO 2 -+ NO 3 -levels than those in the NI groups (Table 4) .
DISCUSSION
Prostaglandins (PG), oxidative metabolites of arachidonic acid, can be found at low levels in most tissues, the products of a constitutive enzyme, COX-1. They are involved in maintaining normal tissue function, as exemplified by their protective roles for the intestinal mucosa, mediation of normal platelet function, and regulation of renal blood flow (Crofford, 1997; Vane et al., 1998) . On the other hand, PG can be produced quickly at sites of infection by COX-2, an induced enzyme upregulated not only in macrophages, but also in other cells and tissues (O'Neill and Ford-Hutchenson, 1993; Crofford, 1997) by inflammatory cytokines produced during immune responses (Vane et al., 1994; Akarasereenont et al., 1995; Goodwin et al., 1999) . The COX-2-elaborated PG can be associated with pathology, including inflammation at lesion sites, fever (Macari et al., 1993; Romanovsky et al., 1999) and muscle wasting (Turinsky and Loegering, 1985; Tian and Baracos, 1989) , and shock (Futaki et al., 1997) . They also have regulating effects on populations of lymphocytes from the thymus (Oghiso et al., 1993; Saiagh et al., 1994; Goetzel et al., 1995; Rocca et al., 1999) .
The role of PG in the pathogenesis of avian coccidiosis has not been explored. Because the immune response to coccidia infections is primarily T cell-mediated (Lillehoj, 1998; Smith and Hayday, 1998) , with interferon-gamma (IFN-γ) acting as a major effector cytokine (Lillehoj and Choi, 1998) , production of PG during coccidiosis might be expected to result in the up-regulation of COX-2 in activated macrophages, other phagocytic cells, or intestinal tissues. The significant increases in plasma NO 2 -+ NO 3 -seen during infection (Allen, 1997; Allen and Lillehoj, 1998 ) are interpreted as measures of increased iNOS activity (Stuehr and Marletta, 1985) and indicate that elaboration of inflammatory modulators from activated phagocytic cells does occur during primary coccidia infections.
Indomethacin is a nonspecific COX inhibitor. In mammalian systems, it inhibits PG and TX biosynthesis (Gilroy et al., 1998) . In preliminary experiments, administration by gavage of 10 mg/kg IM in single daily doses proved fatal. Therefore, several trials were run using smaller single doses. When it was seen that these doses had no adverse effects on the controls, but also no ameliorative effects on depressed weight gain or increased lesion scores, two daily doses, spaced 8 h apart, were tried to maintain more effective blood levels of IM. Several experiments were run to find suitable IM levels to supplement feed in order to provide sustained blood levels of IM. A level of 100 mg/kg proved toxic and resulted in deaths. A level of 50 mg/kg appeared to have no short-term (8 d) adverse effect.
It was expected that IM treatment of E. acervulina-infected chickens might reduce lesion scores and ameliorate the reduction in weight gain that usually attends primary infections. However, in none of the experiments in which chickens received a variety of IM doses and levels of infection did this occur. Rather, IM consistently reduced oocyst output. Interestingly, dietary IM is also reported to reduce oocyst shedding in Cryptosporidium baileyi infections in chickens, an effect interpreted as reversing immunosuppressive effects of PG (Hornok et al., 1999) .
Nimesulide is considered to be a specific inhibitor of COX-2 when given at therapeutic levels. A number of studies have contrasted the differential effects of IM and NIM on prostanoid metabolism in in vivo models (Fa- maey, 1997; Azab et al., 1998; Cullen, et al., 1998; Fukutake et al., 1998; Gilroy et al., 1998; Shah et al., 1999) . Nimesulide caused no fatalities when it was provided in the feed at 400, 100, or 50 ppm. In contrast to IM, treatments with high doses of NIM significantly increased oocyst shed- ding, although only the lowest dose significantly reduced oocyst shedding (Table 3) . It is clear from the literature that both IN and NIM can reduce PG generated by COX-2. However, NIM does not reduce TX synthesis in in vivo experiments, whereas IM does. The COX-2 enzyme is also reported to catalyze the biosynthesis of prostacyclin and PGE 2 , whereas COX-1 also catalyzes the production of TX (Brock et al., 1999) . The ineffectiveness of IM and NIM treatments in reversing weight gain reduction and lesion scores during E. acervulina infections suggests that PG synthesized by up-regulated COX-2 do not play a significant role in these two aspects of the pathology of E. acervulina infections in chickens. Interestingly, Korver et al. (1997) found that reduction of tissue arachidonic acid with dietary fish oil or treatment of chickens infected with E. tenella with the lipoxygenase (LOX) inhibitor, lofrin, counteracted infection-associated weight gain depression. These findings suggest that, in coccidia-infected chickens, LOX activity (which results in synthesis of leukotrienes (LT)) may be up-regulated to a greater extent than COX, and it may be that LT rather than PG act systemically to induce weight gain depression.
The lack of effects of IM and NIM on reductions in plasma carotenoids in the infected groups also suggests that an increase in PG is not likely associated with malabsorption, or with oxidative reactions that might cause reductions in plasma carotenoids. The significant increases in plasma NO 2 -+ NO 3 -in the TI groups compared with the NI groups from IM (Trial 5) and from NIM (Trials 1 and 3) suggest there may be some competitive interaction between COX-2 and iNOS activities during E. acervulina infections (Salvemini et al., 1993; Vane et al., 1994) .
The reduced oocyst shedding brought about by treatments with IM and low doses of NIM suggests that protective T cell immune reactions to E. acervulina that are normally suppressed by PG may have been up-regulated by IM and NIM. These results are consistent with the reported oocyst reductions by IM treatment of C. baileyiinfected chickens (Hornok et al., 1999) . Treatments with IM have also been reported to reduce liver abscesses in hamsters infected with Entamoeba histolytica (SanchezRamirez et al., 1997) , reduce severity of lesions produced by Leishmania major (Farrell and Kirkpatrick, 1987; DeFreitas et al., 1999) , and increase lymphoproliferative responses to Toxoplasma gondii (Hayashi et al., 1996; Delemarre et al., 1998) . In all of these instances, effects have been linked to a reversal of immunosuppressive effects of PG.
Whereas most reports on NIM indicate that its therapeutic activity in vivo is primarily due to inhibition of COX-2, in vitro studies have shown that NIM can also inhibit production of LT and platelet activating factor, and may inhibit activation of phospholipase A2 in human neutrophils, eosinophils, basophils, and mast cells (Casolaro et al., 1993; Tool and Verhoeven, 1995; Tool et al., 1996) . One explanation, then, for the stimulating effect of high doses of NIM on oocyst shedding during E. acervulina infections could be that they had a more general inhibitory effect, perhaps on several cell types, reducing eicosanoids such as LT that may actually be detrimental to the parasite. Also, LTB 4 has been shown to damage tachyzoites of T. gondii (Henderson and Chi, 1998) and to be detrimental to murine cerebral malaria infections (Xiao et al., 1999) .
The processes affected by COX inhibitors (IM or NIM) in chickens infected with E. acervulina do not appear to evoke systemic effects, because the treatments had no beneficial effects on weight gain depression through the 8 All technical help were employees at the author's USDA laboratory, Beltsville, MD 20705. course of infection. On the other hand, the consistent effects on oocyst shedding certainly imply that the treatments with COX inhibitors had significant effects on eicosanoid metabolism at local sites of infection.
The beneficial effects of feeding lofrin, a LOX inhibitor, to E. tenella-infected chickens as reported by Korver et al. (1997) indicate that LT could be generated during the immune response to this species. Whether this is a general response to Eimeria spp. or specific to cecal-dwelling E. tenella remains to be determined. Much more specific information is needed on the in vivo elaboration of eicosanoid products during the immune response of chickens to parasitic infections, such as coccidiosis, in order to assess the contribution of eicosanoid products to the systemic pathology seen in coccidial infections.
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